Network origin in Walter Kittl first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
36
| Subsidiary | Pharmaceuticals: Major | 36 |
| Public Company | Pharmaceuticals: Major | 11 | |
DSM Chemie Linz
 DSM Chemie Linz Chemicals: SpecialtyProcess Industries Part of DSM-Firmenich AG, DSM Chemie Linz is a private company that manufactures chemical intermediates. DSM Chemie Linz is based in Linz, Austria.
1
| Subsidiary | Chemicals: Specialty | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Walter Kittl via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Basel | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Secretary Human Resources Officer | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Siegfried AG
 Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG. | Chemicals: Agricultural | Director/Board Member Director/Board Member Director/Board Member | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Founder Chairman Director/Board Member | |
| International Institute for Management Development | College/University | Director/Board Member Director/Board Member Masters Business Admin | |
| University of St. Gallen | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Roche Glycart AG
 Roche Glycart AG Pharmaceuticals: MajorHealth Technology Roche Glycart AG discovers and develops drugs. It is active in the research and development of new potent antibody-based products for the treatment of unmet clinical needs such as cancer. It uses its proprietary set of technologies to endow therapeutic antibodies. The company has developed glycoengineering technology (GlycoMAb) to boost a natural mechanism of action of therapeutic antibodies developed to mediate target cell killing. The company was founded in 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| UBS | Investment Managers | Director of Finance/CFO Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Freie Universität Berlin | College/University | Doctorate Degree Doctorate Degree | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| POLYPEPTIDE GROUP AG | Biotechnology | Director/Board Member Director/Board Member | |
| REPOWER AG | Electric Utilities | Director/Board Member Director/Board Member | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | General Counsel Director/Board Member | |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| LONZA GROUP AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
LiMM Therapeutics SA
 LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member | |
DayTwo Ltd.
 DayTwo Ltd. Medical/Nursing ServicesHealth Services DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel. | Medical/Nursing Services | Director/Board Member | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Corporate Officer/Principal | |
| Lonza Arena AG | Director/Board Member | ||
| Health Opportunities GmbH | Chief Executive Officer | ||
TargEDys SA
 TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Mint Solutions Holding BV
 Mint Solutions Holding BV Electronic Equipment/InstrumentsElectronic Technology Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member | |
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Financial Conglomerates | Director/Board Member | |
| Hans Kalbermatten Thermalbad AG | Chairman | ||
| École Centrale Paris | College/University | Undergraduate Degree | |
| University of Louisiana at Monroe | College/University | Doctorate Degree | |
| The Rockefeller University | College/University | Doctorate Degree |
Statistics
International
| Switzerland | 22 |
| United States | 11 |
| France | 10 |
| Germany | 6 |
| Israel | 3 |
Sectoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 271 |
| Corporate Officer/Principal | 132 |
| Chairman | 79 |
| Independent Dir/Board Member | 55 |
| Chief Executive Officer | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Bradley Bolzon | 41 |
| Thomas Staehelin | 32 |
| Martin Schmid | 32 |
| Erich Hunziker | 28 |
| Carole Nüchterlein | 26 |
| Colin Bond | 25 |
| Gilbert Achermann | 25 |
| Pamela Kirby | 22 |
| Richard T. Laube | 21 |
| Patrick Baeuerle | 19 |
| Heino von Prondzynski | 19 |
| Eric Forquenot de la Fortelle | 19 |
| Dorothée Anna Deuring | 18 |
| Karen Wagner | 17 |
| Bernhard Furrer | 16 |
- Stock Market
- Insiders
- Walter Kittl
- Company connections